A recent study shows YiDiXie serum tests improve diagnostic accuracy for urothelial carcinoma and may complement imaging.
A mid-stage trial found Regeneron's Lynozyfic eradicated detectable residual multiple myeloma in patients after initial treatment. Elsewhere, researchers found little evidence that GLP-1 drugs affect obesity-related cancer risk, while a large study linked early smartphone ownership with depression, obesity and insufficient sleep.
Discontinued drug for gastrointestinal discomfort
Topical ointment for rheumatic pain relief.
Discontinued acne treatment
Topical antibiotic for skin infections and burns
CNS stimulant for ADHD and narcolepsy
Discontinued topical analgesic
Past use in migraine prevention
Indications and availability
Historical use and regulatory status
A study of older adults with dementia found receipt of the Zostavax shingles vaccine was associated with a lower risk of death from dementia during follow-up. In separate findings, continuous glucose monitoring was associated with lower rates of above-average birth weight among women with gestational diabetes.
A mid-stage trial found the experimental stroke drug scp776 was associated with improved outcomes in patients who arrived at hospital about 12 hours after symptom onset. Elsewhere, an AI tool improved detection of suspicious fetal heart findings on second-trimester ultrasound scans.
A late-stage trial found adding Tukysa to maintenance therapy prolonged progression-free survival in patients with HER2-positive metastatic breast cancer. In related findings, a large study linked GLP-1 drug use in type 2 diabetes with a higher risk of chronic cough.
A study in Uganda found permethrin-treated baby wraps were associated with a lower incidence of malaria in infants compared with untreated wraps. In separate findings, researchers reported that AI cancer-detection models may perform differently across populations and described a framework that reduced diagnostic disparities.
An analysis of language used in grants awarded this year by the U.S. National Institutes of Health suggests that researchers are less likely now than previously to consider study participants' ethnic, racial and gender diversity – or less likely to admit in writing that they plan to do so.
